Related Experiment Video
Updated: Aug 9, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury
Neeta Adhikari1, Nathan Charles, Ute Lehmann
1Cardiovascular Division, University of Minnesota, Mayo Mail Code 508, 420 Delaware Street SE, Minneapolis, MN 55455, USA.
Abstract:
Our understanding of the molecular signaling pathways regulating the initiation and progression of atherosclerosis or remodeling in response to injury has begun to cross the boundaries from regulation of well-described canonical pathways to the interplay between these pathways. The focus of this review is to summarize our current understanding of a finite group of transcription factors and kinases involved in vascular injury and atherosclerosis, including nuclear factor-kappaB (NF-kappaB), early growth response factor-1 (Egr-1), activator protein-1 (AP-1), hypoxia inducible factor-1alpha (HIF-1alpha), homeobox, and T cell factor/lymphoid enhancer factor (Tcf-Lef), as well as the kinases janus kinase/signal transducers and activators of transcription (JAK/STAT), protein kinase C (PKC), p38, Rho, ERK5, JNK, p44/p42, and phosphoinositide 3 (PI3) kinase/AKT.
Insights
This review details key molecular signaling pathways, including transcription factors and kinases, that regulate atherosclerosis and vascular injury. Understanding these interconnected pathways is crucial for developing new therapeutic strategies.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Signaling
Background:
- Atherosclerosis and vascular remodeling involve complex molecular signaling.
- Canonical pathways are well-described, but their interplay is increasingly recognized.
Purpose of the Study:
- To review transcription factors and kinases in vascular injury and atherosclerosis.
- To highlight the interplay between these signaling molecules.
Main Methods:
- Literature review of molecular signaling pathways.
- Focus on specific transcription factors and kinases.
Main Results:
- Identified key regulators: nuclear factor-kappaB (NF-kappaB), early growth response factor-1 (Egr-1), activator protein-1 (AP-1), hypoxia inducible factor-1alpha (HIF-1alpha), homeobox, and T cell factor/lymphoid enhancer factor (Tcf-Lef).
- Summarized roles of kinases: janus kinase/signal transducers and activators of transcription (JAK/STAT), protein kinase C (PKC), p38, Rho, ERK5, JNK, p44/p42, and phosphoinositide 3 (PI3) kinase/AKT.
- Emphasized the interconnectedness of these pathways in disease progression.
Conclusions:
- Current understanding shifts towards the interplay of signaling pathways in atherosclerosis.
- These identified factors and kinases are critical targets for future research and therapeutic interventions.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Atherosclerosis I: Introduction
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades